계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Maverick Therapeutics
company
About
Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers
- 10001 - max
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $125M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2016
- Number Of Employee
- 10001 - max
- Operating Status
- Active
Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers by developing breakthrough T cell immunotherapies with improved safety and efficacy. Their highly innovative platform, COBRA™, is the most advanced bispecific T cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$125M
Maverick Therapeutics has raised a total of
$125M
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2017 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2017 | Series Unknown | $125M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Maverick Therapeutics is funded by 1 investors.
Takeda
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Takeda
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
